Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.6 CAD | -0.62% | +1.27% | -52.24% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.24% | 19.25M | |
+56.74% | 63.85B | |
-1.26% | 41.83B | |
+41.48% | 40.47B | |
-10.02% | 27.17B | |
+12.62% | 26.52B | |
-20.63% | 18.69B | |
+3.11% | 12.73B | |
+22.35% | 12.11B | |
+28.18% | 12.07B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- RBC Capital on Aptose Biosciences' APTIVATE Trial, Cuts Target to US$23